Resonant Appoints Mike Conry as Vice President of Product Development
RF Front End Expert Joins Company from Industry Leading ManufacturerAUSTIN, Texas, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:...
Year: 2021
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
NEWTON, Mass. and GENEVA, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”), a pharmaceutical company focused...
Healthcare Data Startup H1 Acquires Carevoyance, Accelerating Entry into the Fast-Growing Medical Device Market
Carevoyance Territory Manager Medical Device Companies Powered by Territory Manager NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- H1, which...
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Continued progress with the multiple ascending dose (MAD) portion of the Phase 1 clinical trial for LP352, a potential treatment...
United Soybean Board Awards $1 Million to Amfora to Continue Development of High-Protein Soy
Award reflects effort to maintain U.S. soy farmers’ global market shareSAN FRANCISCO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The United...
Metacrine to Present at 2021 Canaccord Genuity Growth Conference
SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients...
TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial
- Trial to Continue as PlannedSAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage...
Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development
Former Pacific Biosciences executive brings deep expertise in single-molecule analysis to large-scale platform designed to comprehensively quantify the proteomeSEATTLE, Aug....
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Commercial and launch preparations on track to support potential U.S. FDA approval of FT218 for the treatment of excessive daytime...
ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor medical AG
SOLANA BEACH, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing...
Impel NeuroPharma Announces Publication of Pivotal Phase 3, Open-Label Stop 301 Study of INP104 (TRUDHESA™) for Treatment of Acute Migraine in the Journal Headache
Study Shows TRUDHESA™ Was Well Tolerated and Delivered Rapid, Consistent Symptom Relief Exploratory Patient-Reported Outcomes Data Indicated More Than One...
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
Top-line results from Phase IIb sepsis trial expected in Q2 2022Phase IIb trial in severe and critical COVID-19 patients planned...
PolyPid to Present at the Investor Summit Virtual Conference on August 18, 2021
PETACH TIKVA, Israel, Aug. 09, 2021 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes...
Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International LtdMINNEAPOLIS, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical...
Vivos Therapeutics Schedules Second Quarter 2021 Financial Results Conference Call
Call Scheduled for Thursday, August 12, 2021 at 5:00 pm ET HIGHLANDS RANCH, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) --...
R1 Introduces R1 Entri™ Platform to Comprehensively Transform Patient Access and Experience Across Care Settings
Solution unifies scheduling, clearance, intake and payments to improve patient/provider experiences and drive financial performance MURRAY, Utah, Aug. 09, 2021...
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference
MENLO PARK, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its...
Daré Bioscience Announces FDA Acceptance and Priority Review of New Drug Application for DARE-BV1 for the Treatment of Bacterial Vaginosis
Six-month priority review granted for DARE-BV1 with PDUFA target action date set for December 7, 2021.NDA supported by positive data...
aTyr Pharma Announces Two Abstracts for ATYR1923 Accepted for Presentation at the European Respiratory Society International Congress
SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery...
InnerScope Hearing Technologies (OTC: INND) Launches Direct-to-Consumer Hearing Aid on FSAstore.com, HSAstore.com, & WellDeservedHealth.com
InnerScope partners with Health-E Commerce to offer Medical-Grade Direct-to-Consumer Hearing Aids to the 70+ million consumers with pre-tax and tax-free...
